News & Perspective

Dec 29, 2006

Dec 29, 2006

Feds detail progress on pandemic preparedness

(CIDRAP News) – In a recent update on pandemic influenza preparedness planning, the US government reported meeting more than 90% of a long list of objectives it set for itself about 6 months ago.

The report charts progress on a wide range of preparedness measures, from shoring up laboratory capabilities to planning for distribution of critical medical supplies and preparing checklists for various sectors of the economy.

Nov 15, 2006

Nov 15, 2006

'Gene chip' test could speed H5N1 diagnosis

(CIDRAP News) – Scientists say they have developed an inexpensive "gene chip" test that can quickly identify a variety of influenza A viruses, including H5N1, and is less apt to be confused by viral mutations than other tests are.

Nov 09, 2006

Nov 09, 2006

Anti-clotting drug may hinder action of Tamiflu

(CIDRAP News) – A laboratory study indicates that the antiplatelet drug clopidogrel (Plavix) may limit the action of the antiviral oseltamivir (Tamiflu), which could mean trouble for cardiovascular disease patients who contract influenza.

Oct 17, 2006

Oct 17, 2006

Baxter says cell-based H5N1 vaccine shows potential in trial

(CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.

Oct 04, 2006

Oct 04, 2006

Groups call for pandemic flu vaccine 'master plan'

(CIDRAP News) – Public health and infectious disease experts today called on the United States to develop a "master plan" for development of pandemic influenza vaccines in order to translate scientific advances more rapidly into improved pandemic preparedness.

Oct 02, 2006

Oct 02, 2006

Injectable drug seen as potential treatment for flu, both seasonal and avian

(CIDRAP News) – Recent tests suggest that an antiviral drug given by intravenous (IV) or intramuscular (IM) injection could eventually serve as another weapon against influenza, according to results presented at a conference last week.

Sep 08, 2006

Sep 08, 2006

Could blood from H5N1 flu survivors help others?

(CIDRAP News) – A recent report about the use of blood products to treat patients in the Spanish influenza pandemic of 1918 has sparked interest among those concerned about the threat of the next pandemic, but experts say it's far from clear whether the approach would be practicable in a pandemic today.

Jul 21, 2006

Jul 21, 2006

HHS adds Relenza to state stockpile program

(CIDRAP News) – The US Department of Health and Human Services (HHS) yesterday announced a contract with GlaxoSmithKline (GSK) that will allow states to add the influenza drug zanamivir (Relenza) to their federally subsidized antiviral stockpiles.

Jul 05, 2006

Jul 05, 2006

HHS has enough H5N1 vaccine for 4 million people

(CIDRAP News) – In an update on pandemic influenza preparedness efforts, the federal government said last week it had stockpiled enough vaccine against H5N1 avian influenza virus to inoculate about 4 million people and enough antiviral medication to treat about 6.3 million.

Jun 07, 2006

Jun 07, 2006

Firm gets funds for work on avian flu DNA vaccine

(CIDRAP News) – Vical Inc., San Diego, announced today it would receive early access to $2.6 million in government funds to help it complete preclinical development of a DNA vaccine for avian influenza.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»